U.S. federal trademark · Serial No. 99222134
Biologics in the nature of pharmaceutical preparations for immunotherapy against cancer; Pharmaceutical and biological preparations for medical therapeutic use in oncology, immunology, and immuno-oncology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing tumors, cancer, and inflammatory disorders; Therapeutic agents for medical use, namely, monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, and engineered antibodies for increasing T-cell activation, increasing phagocytosis, reducing cytokine release, and suppressing over expressing tumors and cancer cells
Custom manufacturing of therapeutic agents, namely, monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, fusion molecular proteins, and engineered antibodies, all for use in pharmaceuticals
Research and development in the fields of immune-oncology, monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, fusion molecular proteins, and pharmaceuticals and biologics in the field of oncology; Providing medical research information in the fields of monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, fusion proteins, and pharmaceuticals and biologics in the field of oncology
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.